Healthy high growth potential

Results

1512

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1512 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$537.65-2.3%75.3%US$12.6bUS$679.6410.959.7%n/aPharmaceuticals & Biotech
FWRY
ج.م19.303.6%55.8%ج.م65.7bج.م22.4524.727.3%n/aDiversified Financials
LITE
US$829.7010.3%712.4%US$65.2bUS$1,104.89147.056.5%n/aTech
CRDO
US$228.270.7%132.0%US$41.7bUS$279.2990.127.7%n/aSemiconductors
NVDA
US$212.062.2%22.1%US$5.1tUS$302.8332.222.8%0.5%Semiconductors
SAUD3
R$15.02-3.1%30.6%R$43.9bR$16.6277.743.7%5.4%Healthcare
MOD
US$249.647.6%152.7%US$13.1bUS$340.86109.149.2%n/aCapital Goods
CORT
US$90.881.5%32.9%US$10.3bUS$106.00209.047.8%n/aPharmaceuticals & Biotech
AXSM
US$239.620.9%125.3%US$12.2bUS$282.5117.457.0%n/aPharmaceuticals & Biotech
NYKAA
₹324.80-0.02%50.6%₹929.9b₹307.92466.248.9%n/aRetail
EIEL
₹217.62-4.1%-21.2%₹38.2b₹346.0020.937.8%n/aCapital Goods
002970
CN¥46.81-9.6%-0.2%CN¥8.5bn/a26.236.5%2.1%Automobiles
NORTHERN
RM 0.692.2%-2.8%RM 273.0mRM 1.0017.939.5%n/aCapital Goods
3636
HK$14.418.8%n/aHK$2.2bHK$31.235.840.2%2.7%Materials
7685
JP¥3,125.00-11.1%120.5%JP¥193.2bJP¥4,666.6726.325.5%0.7%Retail
1729
HK$15.552.0%67.2%HK$34.7bHK$28.7544.337.1%0.3%Capital Goods
6990
HK$521.50-0.2%34.5%HK$124.7bHK$563.1052.345.5%n/aPharmaceuticals & Biotech
1860
HK$10.84-0.3%27.1%HK$16.6bHK$18.2628.541.1%n/aMedia
2171
HK$14.41-15.6%-41.7%HK$8.6bHK$21.1958.980.6%n/aPharmaceuticals & Biotech
3881
HK$18.59-3.6%n/aHK$8.1bn/a7.9107.1%n/aCapital Goods
4417
JP¥4,230.00-4.4%44.9%JP¥63.5bJP¥4,500.0042.724.1%1.2%Software
6223
NT$6,250.000.5%495.2%NT$612.4bNT$8,228.00166.457.5%0.4%Semiconductors
605376
CN¥146.41-11.8%268.0%CN¥38.3bCN¥120.50157.745.7%0.07%Materials
APOLLO
₹395.50-0.7%130.4%₹148.7b₹382.50131.741.3%0.06%Capital Goods
Page 1 of 42
Healthy high growth potential - Investing Ideas - Simply Wall St